Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute toxic renal failure.

Pieter Evenepoel1

  • 1Division of Nephrology, Department of Medicine, University Hospital Leuven, B-3000 Leuven, Belgium. pieter.evenepoel@uz.kuleuven.ac.be

Best Practice & Research. Clinical Anaesthesiology
|February 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential therapeutic approach for the management of osteoporosis in people with chronic kidney disease.

Nature reviews. Nephrology·2026
Same author

Case-Control and Longitudinal Study of Sex Steroids in Male Patients with CKD Before and After Kidney Transplantation.

Kidney international reports·2026
Same author

Liver fraction of circulating alkaline phosphatase is elevated in chronic kidney disease and associates with mortality in patients treated with haemodialysis.

Clinical kidney journal·2026
Same author

Kidney Function Modulates Gut Microbial Metabolism.

Toxins·2026
Same author

Fracture risk after kidney transplantation: unchanged and unaddressed: a registry-based cohort study across two decades.

Clinical kidney journal·2026
Same author

Diagnosis and management of mineral and bone disorders in paediatric kidney transplant recipients: a position statement from the European Society for Paediatric Nephrology.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Reimagining cardiac surgery-the emerging role of prehabilitation and risk optimization.

Best practice & research. Clinical anaesthesiology·2026
Same journal

Prehabilitation and enhanced recovery after cardiac surgery.

Best practice & research. Clinical anaesthesiology·2026
Same journal

The role of biomarkers in the preoperative evaluation of cardiac surgical patients - A narrative review.

Best practice & research. Clinical anaesthesiology·2026
Same journal

Magic in a bottle? A Focused review of factor concentrates for the intraoperative treatment of acquired coagulopathy - Fibrinogen concentrate, prothrombin complex concentrate, and recombinant activated factor VII.

Best practice & research. Clinical anaesthesiology·2025
Same journal

ESAs in perioperative anemia management: Who, what, how and why?

Best practice & research. Clinical anaesthesiology·2025
Same journal

Does patient blood management represent good value for money?

Best practice & research. Clinical anaesthesiology·2025
See all related articles

Acute renal failure (ARF), a common intensive care issue, significantly raises mortality risk. Identifying and mitigating exposure to nephrotoxic drugs and endogenous compounds is crucial for prevention and management.

Area of Science:

  • Nephrology
  • Intensive Care Medicine
  • Toxicology

Background:

  • Acute renal failure (ARF) is a frequent and serious complication in intensive care units.
  • Even mild ARF not requiring dialysis increases mortality risk fivefold.
  • Nephrotoxic agents, both exogenous drugs and endogenous compounds, play a significant role in ARF etiology.

Purpose of the Study:

  • To highlight the ongoing contribution of nephrotoxic drugs to ARF.
  • To identify key nephrotoxic agents and risk factors for ARF.
  • To emphasize preventive strategies for drug-induced ARF.

Main Methods:

  • Review of literature on nephrotoxic agents and ARF.
  • Identification of common drug classes and endogenous substances causing nephropathy.

Related Experiment Videos

  • Analysis of risk factors predisposing patients to ARF.

    • Main Results:

    • Potentially nephrotoxic drugs include NSAIDs, radiocontrast agents, antimicrobials, and anesthetics.
    • Endogenous toxins like myoglobin and hemoglobin can also cause toxic nephropathy.
    • Risk factors include reduced renal reserve, comorbidities (cardiovascular, diabetes), and advanced age.

    Conclusions:

    • Awareness of nephrotoxins is essential for preventing ARF.
    • Simple measures like pre-hydration and drug monitoring can mitigate ARF risk.
    • Proactive management can reduce the incidence and severity of drug-induced ARF in susceptible patients.